← 홈

ADC

1,032개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,032개
ADCBiologicSeagen Inc.Vedotin for Relapsed or Ref…Phase 2

SGN-35 (SGN-35)

Disease, Hodgkin; Lymphoma, Large-Cell, Anaplastic · Disease, Hodgkin

#DiseaseHodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 93%임상시험 57상태 ACTIVE
ADCBiologicAbbViePhase 3

Steroid eye drops (Steroid eye drops)

Glioblastoma Multiforme · Glioblastoma Multiforme

#GlioblastomaMultiforme#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 6%임상시험 57상태 DISCONTINUED
ADCBiologicstalePfizerderuxtecan and tucatinibPhase 3

Tucatinib (Tucatinib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
ADCBiologicstaleRocheDM1 via butelase-1 with ABD…Phase 2

ado-trastuzumab emtansine (Kadcyla, T-DM1)

Bone Metastases; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 69.7%임상시험 57상태 ACTIVE
ADCBiologicstaleEpizyme, Inc.Phase 2

Abiraterone + prednisone (Abiraterone + prednisone)

Metastatic Prostate Cancer; Metastatic Castration-resistant Prostate Cancer · mCRPC

#mCRPC#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 46%임상시험 56상태 RECRUITING
ADCBiologicAstraZenecaPhase 2

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64.3%임상시험 56상태 RECRUITING
ADCBiologicSerum Life Science Europe GmbHPhase 2

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression · Non-muscle Invasive Bladder Cancer

#Non-muscleInvasiveBladderCancer#ADC#Phase2#인기#항체약물접합체+4
임상시험 56상태 RECRUITING
ADCBiologicstaleSeagenvedotin-containing regimen …Phase 2

BV (BrentuximabVedotin, BrentuximabVedotin (BV))

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 2%임상시험 56상태 ACTIVE
ADCBiologicMing-Yuan ChendeliveryPhase 3

Neoadjuvant and Adjuvant Immunotherapy (Neoadjuvant and Adjuvant Immunotherapy)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 10%임상시험 56상태 RECRUITING
ADCBiologicstaleBeijing InnoCare Pharma Tech Co…Phase 3

Orelabrutinib (Orelabrutinib)

Primary Central Nervous System Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#ADC#Phase3#인기#항체약물접합체+3
임상시험 56상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.sPhase 2

disitamab vedotin (Disitamab Vedotin, RC48)

Non-Muscle Invasive Bladder Cancer; HER2 · Gastric Cancer/Gastroesophageal Junction

#GastricCancerGastroesophagealJun#ADC#Phase2#인기#항체약물접합체+5
임상시험 56상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCaxisPhase 1

sacituzumab govitecan (Trodelvy, Sacituzumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 33.3%임상시험 56상태 ACTIVE
ADCBiologicDaiichi SankyoDM1) and trastuzumab deruxt…Phase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzmab deruxtecan)

Gastric Cancer; Gastroesophageal Junction (GEJ) Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 71.7%임상시험 56상태 RECRUITING
ADCBiologicNuvalent Inc.Preclinical

TKIs (TKIs)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#인기#항체약물접합체+2
효능 ORR 8%임상시험 56상태 ACTIVE
ADCBiologicstaleFortis Therapeutics, Inc.Phase 2

FOR46 (FOR46)

Multiple Myeloma; Multiple Myeloma in Relapse · Prostate Cancer Metastatic

#ProstateCancerMetastatic#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 51.5%임상시험 55상태 RECRUITING
ADCBiologicstaleClovis Oncology, Inc.vedotin after avelumabPhase 1

Gemcitabine/Cisplatin I (Gemcitabine/Cisplatin I)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 45.2%임상시험 55상태 ACTIVE
ADCBiologicAstraZenecaSN-38Phase 2

Nanoliposomal Irinotecan (Nanoliposomal Irinotecan)

Biliary Tract Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 7.7%임상시험 55상태 ACTIVE
ADCBiologicstaleOHSU Knight Cancer InstituteDM4-6 inhibitors (KDMi), ML…Phase 1

Panobinostat (Panobinostat)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 80.6%임상시험 55상태 DISCONTINUED
ADCBiologicstaleMerck Sharp & Dohme LLCGovitecan in gynecologic ma…Phase 3

sacituzumab govitecan (Trodelvy, Sacituzumab tirumotecan)

Lung Neoplasm Malignant · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+5
임상시험 55상태 RECRUITING
ADCBiologicstaleEric Thompson, M.D.DM1 and Metronomic Temozolo…Phase 1

21-day TMZ (21-day TMZ)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 14%임상시험 54상태 DISCONTINUED

11 / 52 페이지

← 이전다음 →